Tag: FDA

Court Rejects Antiabortion Challenge to Mifepristone

May 15, 2026

Court Rejects Antiabortion Challenge to Mifepristone

Trump Reportedly Plans to Dismiss FDA Commissioner Marty Makary

May 11, 2026

Trump Reportedly Plans to Dismiss FDA Commissioner Marty Makary

Former FDA leaders, pharma speak out on mifepristone

May 9, 2026

Former FDA leaders, pharma speak out on mifepristone

Federal Court Blocks Mailing of Mifepristone Abortion Pill

May 3, 2026

Federal Court Blocks Mailing of Mifepristone Abortion Pill

FDA Proposes Ban on Compounded GLP-1 Weight-Loss Drugs

April 30, 2026

FDA Proposes Ban on Compounded GLP-1 Weight-Loss Drugs

FDA Grants Priority Review Vouchers for Psychedelic Drugs to Treat Depression and PTSD Under Trump Administration Plan

April 26, 2026

FDA Grants Priority Review Vouchers for Psychedelic Drugs to Treat Depression and PTSD Under Trump Administration Plan

FDA Recalls Xanax Due to Dissolution Failure

April 17, 2026

FDA Recalls Xanax Due to Dissolution Failure

Hunter Syndrome: New Drug Approval and the Path Forward

April 14, 2026

Hunter Syndrome: New Drug Approval and the Path Forward

GAO Report: DOJ Struggles to Crack Down on Illegal E-Cigarettes

April 11, 2026

GAO Report: DOJ Struggles to Crack Down on Illegal E-Cigarettes

FDA Rejects Replimune’s Experimental Skin Cancer Treatment Again

April 10, 2026

FDA Rejects Replimune’s Experimental Skin Cancer Treatment Again

Web Analytics Made Easy - Statcounter